These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6996035)

  • 1. Demonstration of PGI2 production by isolated perfused rat lungs with platelet aggregation test.
    Hartiala J; Toivonen H; Uotila P
    Prostaglandins; 1980 Jul; 20(1):127-34. PubMed ID: 6996035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The modification of the biosynthesis and effect of thromboxane A2 and prostacyclin by trapidil (Rocornal)].
    Block HU; Heinroth I; Giessler C; Pönicke K; Mentz P; Zehl U; Rettkowski W; Dunemann A; Förster W
    Biomed Biochim Acta; 1983; 42(2-3):283-99. PubMed ID: 6411078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of ibuprofen dose on rabbit platelet aggregation and aortic pgi2 synthesis.
    Adesuyi SA; Ellis EF
    Thromb Res; 1982 Nov; 28(4):581-5. PubMed ID: 6761894
    [No Abstract]   [Full Text] [Related]  

  • 4. The effects of continuous infusions of prostacyclin-Na (epoprostenol-sodium) on platelet counts, ADP-induced aggregation, and cyclic AMP levels in normal volunteers.
    Reele SB; Miller OV; Spillers C; Gorman RR
    Prostaglandins; 1983 Aug; 26(2):287-302. PubMed ID: 6316420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of endogeneous PGI2 generation from isolated rat aortae by MK-447.
    Harada Y; Tanaka K; Katori M
    Jpn J Pharmacol; 1981 Oct; 31(5):845-8. PubMed ID: 6796739
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G; Silver MJ; de Gaetano G
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of anaphylactic mediator release from guinea-pig perfused lungs by fatty acid hydroperoxides.
    Adcock JJ; Garland LG; Moncada S; Salmon JA
    Prostaglandins; 1978 Aug; 16(2):163-77. PubMed ID: 81494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to carbon monoxide or to nicotine does not inhibit PGI2 formation by rat arterial rings incubated with human platelet-rich plasma.
    Hartiala J; Simberg N; Uotila P
    Artery; 1982; 10(6):412-9. PubMed ID: 6760833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of pH on the prostacyclin (PGI2) mediated inhibition of platelet function.
    Rao GH; Reddy KR; Hagert K; White JG
    Prostaglandins Med; 1980 Apr; 4(4):263-73. PubMed ID: 6994159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effect of prostaglandins and an aortic proteoglycan on platelet aggregation and plasma clotting.
    Ts'ao C; Eisenstein R
    Prostaglandins Med; 1979 Sep; 3(3):159-66. PubMed ID: 399532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dipyridamole on prostaglandin generation by human platelets and vessel walls.
    Mehta J; Mehta P; Hay D
    Prostaglandins; 1982 Dec; 24(6):751-61. PubMed ID: 6820166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of whole blood platelet aggregation by nicardipine, and synergism with prostacyclin in-vitro.
    Greer IA; Walker JJ; McLaren M; Calder AA; Forbes CD
    Thromb Res; 1986 Feb; 41(4):509-18. PubMed ID: 3083526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolism of arachidonic acid to an antiaggregatory compound in isolated lungs of fetal and neonatal rabbits.
    Simberg N; Hartiala J
    Prostaglandins; 1982 Dec; 24(6):873-80. PubMed ID: 6820167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aggregation and thromboxane B2 formation in platelets and vascular prostacyclin production from genetically obese rats.
    Landgraf-Leurs MM; Loy A; Christea C; Weber PC; Siess W; Herberg LL; Landgraf R
    Prostaglandins; 1981 Oct; 22(4):521-36. PubMed ID: 6798637
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of inhibitory actions of prostacyclin and a new prostacyclin analogue on the aggregation of human platelet in whole blood.
    Saniabadi AR; Belch JJ; Lowe GD; Barbenel JC; Forbes CD
    Haemostasis; 1987; 17(3):147-53. PubMed ID: 2440771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin (PGI2) inhibits the development in human platelets of ADP and arachidonic acid-induced shape change and procoagulant activity.
    Ehrman ML; Jaffe EA
    Prostaglandins; 1980 Dec; 20(6):1103-16. PubMed ID: 7010448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of platelet aggregation by a new agent, 5-(Z,E)-13,14-didehydro-20-methyl-carbo PGI2 (FCE 22509).
    Bergamaschi M; Pierucci L; Ferti C; Corsi G; Branzoli U; Mandelli V
    Prostaglandins Leukot Med; 1984 Oct; 16(1):19-27. PubMed ID: 6393142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.